Literature DB >> 28681337

Assessing arrhythmic risk with 123I-mIBG and analogous tracers: Image interpretation from a different viewpoint.

Mark I Travin1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28681337     DOI： 10.1007/s12350-017-0968-y

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  29 in total

1.  Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients.

Authors:  Mark J Boogers; C Jan Willem Borleffs; Maureen M Henneman; Rutger J van Bommel; Jan van Ramshorst; Eric Boersma; Petra Dibbets-Schneider; Marcel P Stokkel; Ernst E van der Wall; Martin J Schalij; Jeroen J Bax
Journal:  J Am Coll Cardiol       Date:  2010-06-15       Impact factor: 24.094

Review 2.  Implantable cardioverter-defibrillators after myocardial infarction.

Authors:  Robert J Myerburg
Journal:  N Engl J Med       Date:  2008-11-20       Impact factor: 91.245

3.  Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death.

Authors:  T Wakabayashi; T Nakata; A Hashimoto; S Yuda; K Tsuchihashi; M I Travin; K Shimamoto
Journal:  J Nucl Med       Date:  2001-12       Impact factor: 10.057

Review 4.  Fractal and multifractal analysis: a review.

Authors:  R Lopes; N Betrouni
Journal:  Med Image Anal       Date:  2009-05-27       Impact factor: 8.545

5.  Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy.

Authors:  James A Fallavollita; Brendan M Heavey; Andrew J Luisi; Suzanne M Michalek; Sunil Baldwa; Terry L Mashtare; Alan D Hutson; Robert A Dekemp; Michael S Haka; Munawwar Sajjad; Thomas R Cimato; Anne B Curtis; Michael E Cain; John M Canty
Journal:  J Am Coll Cardiol       Date:  2013-09-25       Impact factor: 24.094

6.  Does the Implantable Cardioverter-Defibrillator Benefit Vary With the Estimated Proportional Risk of Sudden Death in Heart Failure Patients?

Authors:  Wayne C Levy; Yanhong Li; Shelby D Reed; Michael R Zile; Ramin Shadman; Todd Dardas; David J Whellan; Kevin A Schulman; Stephen J Ellis; Matthew Neilson; Christopher M O'Connor
Journal:  JACC Clin Electrophysiol       Date:  2017-03

7.  Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidine.

Authors:  M S Stanton; M M Tuli; N L Radtke; J J Heger; W M Miles; B H Mock; R W Burt; H N Wellman; D P Zipes
Journal:  J Am Coll Cardiol       Date:  1989-11-15       Impact factor: 24.094

8.  Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate variability, and QT dispersion.

Authors:  Shunsuke Tamaki; Takahisa Yamada; Yuji Okuyama; Takashi Morita; Shoji Sanada; Yasumasa Tsukamoto; Masaharu Masuda; Keiji Okuda; Yusuke Iwasaki; Taku Yasui; Masatsugu Hori; Masatake Fukunami
Journal:  J Am Coll Cardiol       Date:  2009-02-03       Impact factor: 24.094

Review 9.  Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review.

Authors:  Hein J Verberne; Lizzy M Brewster; G Aernout Somsen; Berthe L F van Eck-Smit
Journal:  Eur Heart J       Date:  2008-03-17       Impact factor: 29.983

10.  Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study.

Authors:  Alfred E Buxton; Kerry L Lee; Gail E Hafley; Luis A Pires; John D Fisher; Michael R Gold; Mark E Josephson; Michael H Lehmann; Eric N Prystowsky
Journal:  J Am Coll Cardiol       Date:  2007-09-04       Impact factor: 24.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.